Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) has shared an update.
Shanghai MicroPort MedBot (Group) Co., Ltd., a Hong Kong-listed Chinese medical technology company specializing in robotic-assisted surgical systems, continues to refine its capital structure to support its growth in domestic and global healthcare markets. The group’s focus on innovative surgical devices positions it within the rapidly evolving medtech segment, where access to international investors is increasingly important.
The company has completed the conversion of 5,989,798 previously unlisted shares into H shares, with trading of these converted shares on the Hong Kong Stock Exchange starting on 24 April 2026. Following the conversion, H shares now represent approximately 99.94% of the company’s total issued share capital, significantly increasing share circulation in the Hong Kong market and potentially improving liquidity for existing and prospective investors.
The restructuring leaves only about 0.06% of the company’s shares unlisted, marking near-full H share circulation and simplifying the overall shareholding structure. The board has cautioned shareholders and potential investors to exercise care when dealing in the company’s shares, underscoring the sensitivity of the stock to changes in market perception as the enlarged free float begins trading.
The most recent analyst rating on (HK:2252) stock is a Buy with a HK$45.00 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. is a China-based medical technology company focused on robotic-assisted surgery and related medical devices. Listed in Hong Kong under stock code 2252, the group targets both domestic and international healthcare markets with advanced surgical solutions and aims to strengthen its presence through enhanced capital market access.
Average Trading Volume: 7,057,589
Technical Sentiment Signal: Buy
Current Market Cap: HK$36.34B
Learn more about 2252 stock on TipRanks’ Stock Analysis page.